|
Vanguard Total Stock Market Index Fund ETF Shares | VTI | Gotham Neutral Fund Institutional Class | GONIX | Armor US Equity Index ETF | ARMR | Kelly CRISPR & Gene Editing Technology ETF | XDNA | Renaissance International IPO ETF | IPOS | Vanguard Consumer Staples Index Fund ETF Shares | VDC | Point Bridge America First ETF | MAGA | DocuSign Inc | DOCU | Natixis Vaughan Nelson Select Fund Class C | VNSCX | Natixis Vaughan Nelson Select Fund Class N | VNSNX |
Gross Expense Ratio*
0.03%
SEC 30 Day Yield (as of 12/31/22 )
1.65%
Ann. Dividend/Yield
$3.18/1.56%
Ex-Dividend Date
12/22/2022
52-Wk Range
174.84 - 233.36
Fund Inception
05/24/2001
|
 Loading...
The chart is currently unavailable.
|
The investment seeks to track the performance of the CRSP US Total Market Index that measures the investment return of the overall stock market.The fund employs an indexing investment approach designed to track the performance of the index, which represents approximately 100% of the investable U.S. stock market and includes large-, mid-, small-, and micro-cap stocks. It invests by sampling the index, meaning that it holds a broadly diversified collection of securities that, in the aggregate, approximates the full index in terms of key characteristics.
|
Market Return % (as of 12/31/2022) |
NAV Return % (as of 12/31/2022) |
Market Return % (as of 12/31/2022) |
NAV Return % (as of 12/31/2022) |
1-Month |
-5.85% |
-5.87% |
-5.85% |
-5.87% |
3-Month |
+7.05% |
+7.15% |
+7.05% |
+7.15% |
6-Month |
+2.30% |
+2.39% |
+2.30% |
+2.39% |
Year-to-date |
-19.51% |
-19.50% |
-19.51% |
-19.50% |
1-Year |
-19.51% |
-19.50% |
-19.51% |
-19.50% |
3-Year |
+6.97% |
+6.97% |
+6.97% |
+6.97% |
5-Year |
+8.68% |
+8.72% |
+8.68% |
+8.72% |
10-Year |
+12.07% |
+12.08% |
+12.07% |
+12.08% |
Since Inception |
+7.67% |
+7.52% |
+7.67% |
+7.52% |
Inception Date: May 24, 2001
Performance Details
Total return reflects performance without adjusting for sales charges or the effects of taxation, but is adjusted to reflect all actual ongoing fund expenses and assumes reinvestment of dividends and capital gains. If adjusted, sales charges would reduce the performance quoted. Performance data quoted represents past performance, is no guarantee of future results, and may not provide an adequate basis for evaluating the performance potential of the product over varying market conditions or economic cycles. Current performance may be higher or lower than the performance data quotes. The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost.
|
Market Return % (as of 12/31/2022) |
NAV Return % (as of 12/31/2022) |
Market Return % (as of 12/31/2022) |
NAV Return % (as of 12/31/2022) |
1-Year |
-19.51% |
-19.50% |
-19.51% |
-19.50% |
5-Year |
+8.68% |
+8.72% |
+8.68% |
+8.72% |
10-Year |
+12.07% |
+12.08% |
+12.07% |
+12.08% |
Since Inception |
+7.67% |
+7.52% |
+7.67% |
+7.52% |
Inception Date: May 24, 2001
2.65% |
9.77% |
2.65% |
27.21% |
13.93% |
3.51% |
Defensive |
25.74% |
6.98% |
15.69% |
3.07% |
Sensitive |
44.41% |
6.71% |
5.15% |
10.07% |
22.48% |
Portfolio Details
|
* represents an International company or one without a recognizable symbol.
Portfolio Details
|
|
|